0.07%| Prev Close: | 54.56 |
|---|---|
| Open: | 54.80 |
| Bid: | 53.96 x 200 |
| Ask: | 69.99 x 100 |
| 1y Target Est: | 68.53 |
| Beta: | 1.07 |
| Next Earnings Date: | N/A |
| Day's Range: | 54.36 - 54.88 |
|---|---|
| 52wk Range: | 33.03 - 55.86 |
| Volume: | 1,340,738 |
| Avg Vol (3m): | 2,435,270 |
| Market Cap: | 145.20B |
| P/E (ttm): | 27.04 |
| EPS (ttm): | 2.03 |
| Div & Yield: | 1.30 (2.40%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Encouraging News for Peregrine PharmaZacks(Fri May 24)
- The Coming Diabetes Warsat Motley Fool(Thu May 23)
- 4 Contagion Playsat Forbes(Thu May 23)
- Sanofi Stock Buy Recommendation Reiterated (SNY)at TheStreet(Thu May 23)
- Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofiat theflyonthewall.com(Thu May 23)
- Another Multiple Sclerosis Winner for Biogenat Motley Fool(Wed May 22)
- Sanofi/REGN's Dupilumab Data PublishedZacks(Wed May 22)
- Regeneron and Sanofi: An Unstoppable Biotech Duo?at Motley Fool(Tue May 21)
- New Drug May Help Some Asthmatics, Study Findsat New York Times(Tue May 21)
- Elan Continues To Make Baffling Strategic Decisionat Investopedia(Tue May 21)
- Will Influenza A H7N9 Generate Opportunities For Pharma?at Seeking Alpha(Tue May 21)
- New Asthma Drug Generates Excitement For Patients -- And Its Makerat Forbes(Tue May 21)
- Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of MedicinePR Newswire(Tue May 21)
- Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global ConsolidationBusiness Wire(Tue May 21)
- Sanofi (SNY): Today's Featured Drugs Laggardat TheStreet(Mon May 20)
Press Releases
- Finding the Next Big Blockbuster DrugAccesswire(Thu May 16)
- Sanofi Recognizes Nurses as part of National Nursing WeekCNW Group(Wed May 8)
- Sanofi Canada Inaugurates New Corporate Head Office in Laval, QuebecCNW Group(Mon May 6)
Must Read
- Weather still not co-operating as Jersey shore seeks to jump-start 1st summer after SandyThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Closed business in Corner Brook an eyesore, says board of tradeCBC(1969-12-31T18:59:59GMT-05:00)
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(1969-12-31T18:59:59GMT-05:00)